Prosecution Insights
Last updated: October 27, 2026

Makenna Ryleigh Miller, USPTO Patent Examiner

Listed by the USPTO as MILLER, MAKENNA RYLEIGH

Tech Center 4100 • Art Units: 1611 1614 4100

This examiner grants 100% of resolved cases

Analysis

MILLER, MAKENNA RYLEIGH is assigned to tech center 4100 and art unit 1611. The available record contains 3 resolved cases, with an allowance rate of 100.0% and a median of 1098 days to allowance. The interview lift is 0.0%, so the record shows allowance without a measured interview effect, although the limited sample sharply restricts generalization.

The listed companies are Emplicure AB (Publ), Boston Scientific Corporation, and National Institute of Advanced Industrial Science and Technology. The leading firms are BIRCH STEWART KOLASCH & BIRCH, LLP, FOLEY & LARDNER LLP, and ARENTFOX SCHIFF LLP. Practitioners should regard these figures as preliminary indicators rather than a stable basis for predicting future examination.

Written from this page's own data; every figure is computed from USPTO records and verified before publication.

Performance Statistics

100.0%
Allow Rate
+40.0% vs TC avg
30
Total Applications
+0.0%
Interview Lift
1098
Avg Prosecution Days
Based on 3 resolved cases, 2023–2026

Rejection Statute Breakdown

5.4%
§101 Eligibility
13.0%
§102 Novelty
48.9%
§103 Obviousness
23.9%
§112 Clarity

Currently Pending Office Actions

App #TitleStatusAssignee
18650661 INJECTABLE COMPOSITIONS AND RELATED METHODS Non-Final OA Boston Scientific Scimed, Inc.
18847363 METHOD FOR PRESERVING SOLID COMPOSITION THAT CONTAINS FORM II TYPE CRYSTALS OF REDUCED COENZYME Q10, AND PACKING THAT CONTAINS SAID SOLID COMPOSITION Non-Final OA KANEKA CORPORATION
18993836 NEW AGROCHEMICAL FORMULATIONS Non-Final OA BASF SE
18785831 PROCESS FOR TREATING KERATINOUS MATERIAL, COMPRISING THE MIXING OF AT LEAST TWO AGENTS (A) AND (B) Non-Final OA Henkel AG & Co. KGaA
18460146 COMPOSITION FOR PRODUCING A BONE REPLACEMENT MATERIAL, METHOD FOR PRODUCING A PHARMACEUTICAL EXCIPIENT, PHARMACEUTICAL EXCIPIENT, AND USE THEREOF Final Rejection Heraeus Medical GmbH
18540979 EYELASH COATING COMPOSITIONS FOR FALSE EYELASHES Final Rejection L'OREAL
18902326 Personal Care Compositions Final Rejection Colgate-Palmolive Company
18852696 FUNCTIONALIZED CORE-SHELL NANOGEL SCAVENGER FOR IMMUNE MODULATION THERAPY Non-Final OA The Research Foundation for the State University of New York

Facing This Examiner?

IP Author analyzes examiner patterns and generates tailored response strategies with the highest chance of allowance.

Build Your Strategy

Who Appears Before This Examiner

Top companies before this examiner

Law firms appearing most often

Frequently Asked Questions

What is examiner Makenna Ryleigh Miller's allowance rate?

100.0% of resolved applications examined by Makenna Ryleigh Miller were allowed (3 resolved cases), compared with 35.0% across Art Unit 1611 over the last five years.

Does an interview help with examiner Makenna Ryleigh Miller?

This examiner's interview lift is +0.0 percentage points: the difference in allowance rate between resolved applications that had an examiner interview and those that did not.

How long does examiner Makenna Ryleigh Miller take to allow a patent?

Applications allowed by Makenna Ryleigh Miller took 1,098 days on average from filing to allowance.

Which art unit does examiner Makenna Ryleigh Miller work in?

Makenna Ryleigh Miller examines applications in Art Unit 1611 in Tech Center 4100.

Sign in with your work email

Enter your email to receive a magic link. No password needed.

Personal email addresses (Gmail, Yahoo, etc.) are not accepted.

Free tier: 3 strategy analyses per month